Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KIT-302 (Amlodipine + Celecoxib) in Hypertension
NCT02172040Phase 3Completed
- Sponsor
- Purple Biotech Ltd.
- Start
- Jun 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amlodipine, celecoxib oral solution in hypertension (HTN), sponsored by Purple Biotech Ltd.. Started Jun 2014; status: completed.
02
Drugs
amlodipinecelecoxib oral solution
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02172040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172040.